Janux Therapeutics Plans to Use Proceeds for Clinical Development of Internal Product Pipeline, General Corporate Purposes >JANX
Janux Therapeutics Plans to Use Proceeds for Clinical Development of Internal Product Pipeline, General Corporate Purposes >JANX
Janux Therapeutics计划利用收益进行内部产品管线的临床开发和一般企业用途>JANX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间